• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CEA-Scan MoAb agent cleared in Europe

Article

Immunomedics of Morris Plains, NJ, last week announced that ithas received clearance from the European Commission to marketits CEA-Scan colorectal cancer imaging agent in the 15 countriesof the European Union. The monoclonal-antibody-based agent

Immunomedics of Morris Plains, NJ, last week announced that it

has received clearance from the European Commission to market

its CEA-Scan colorectal cancer imaging agent in the 15 countries

of the European Union. The monoclonal-antibody-based agent received

U.S. clearance in June (SCAN 7/17/96). Mallinckrodt Medical of

St. Louis has marketing rights to CEA-Scan in both the U.S. and

Europe.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.